[Is it possible to-predict fracture in CKD patients?]

Area of Science:

• Nephrology
• Endocrinology
• Orthopedics

Background:

• Bone mineral density (BMD) assessment is crucial for fracture risk stratification in chronic kidney disease (CKD).
• CKD-mineral and bone disorder (CKD-MBD) significantly impacts bone health and fracture risk.
• Dual energy X-ray absorptiometry (DXA) is a standard method for measuring BMD.

Purpose of the Study:

• To evaluate the utility of BMD measured by DXA in predicting bone fractures in non-dialysis and dialysis CKD patients.
• To determine if fracture prediction by BMD differs between genders.
• To assess the influence of serum parathyroid hormone (PTH) and bone-specific alkaline phosphatase (BSAP) on BMD's predictive power for fractures.

Main Methods:

• Retrospective analysis of BMD measurements using DXA in CKD patients.
• Correlation of BMD values with documented bone fracture events.
• Statistical analysis to compare predictive values between genders and in relation to serum PTH and BSAP levels.

Main Results:

• BMD measured by DXA is a significant predictor of bone fractures in both non-dialysis and dialysis CKD populations.
• The optimal cutoff value for BMD to predict fractures differs between males and females.
• BMD's predictive accuracy for fractures is higher in patients with lower serum PTH levels.
• Elevated serum bone-specific alkaline phosphatase (BSAP) levels are a stronger predictor of bone fracture than serum PTH levels.

Conclusions:

• DXA-based BMD assessment is a valuable tool for predicting bone fractures in CKD patients.
• Gender-specific BMD cutoff values should be considered for accurate fracture risk assessment.
• Serum BSAP is a more potent predictor of bone fractures in CKD patients compared to serum PTH.